A detailed history of Bank Of America Corp transactions in Equillium, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 467 shares of EQ stock, worth $350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
467
Previous 158 195.57%
Holding current value
$350
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.64 - $1.13 $197 - $349
309 Added 195.57%
467 $0
Q2 2024

Aug 14, 2024

BUY
$0.66 - $2.33 $104 - $368
158 New
158 $0
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.74 $5 - $8
12 New
12 $0
Q4 2022

Feb 10, 2023

BUY
$0.83 - $2.26 $18 - $49
22 New
22 $0
Q1 2022

May 16, 2022

SELL
$2.99 - $4.19 $101 - $142
-34 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$3.77 - $6.99 $128 - $237
34 New
34 $0
Q3 2021

Nov 15, 2021

SELL
$4.84 - $6.91 $33 - $48
-7 Closed
0 $0
Q2 2021

Sep 13, 2021

BUY
$5.11 - $7.64 $35 - $53
7 New
7 $0

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $25.8M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.